Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (Human Immunodeficiency Virus)-inactivating protein

Biochemical and Biophysical Research Communications

Volumn 238, Issue 1, 1997, Pages 218-222

  Mori, Toshiyuki ^a   Shoemaker, Robert H ^a   Gulakowski, Robert J ^a   Krepps, Benjamin L ^a   McMahon, James B ^a   Gustafson, Kirk R ^a   Pannell, Lewis K ^b   Boyd, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYANOVIRIN N; DNA; GLYCOPROTEIN GP 120; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISULFIDE BOND; DRUG PROTEIN BINDING; DRUG STRUCTURE; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; VIRUS INACTIVATION;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031559753     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7202     Document Type: Article

References (9)

1. Boyd M. R., Gustafson K. R., McMahon J. B., Shoemaker R. H., O'Keefe B. R., Mori T., Gulakowski R. J., Wu L., Rivera M. I., Laurencot C. M., Currens M. J., Cardellina J. H. II, Buckheit R. W. Jr., Nara P. L., Pannell L. K., Sowder R. C. II, Henderson L. E. Antimicrob. Agents Chemother. 41:1997;1521-1530.
2. K. R. Gustafson, R. C. Sowder, L. E. Henderson, J. H. Cardellina, II, J. B. McMahon, U. Rajamani, L. K. Pannell, M. R. Boyd, 1997.
3. Daar E., Li W. L., Moudgli T., Ho D. Proc. Natl. Acad. Sci. USA. 87:1990;6574-6578.
4. Moore J. P., Mckeating J. A., Huang Y., Ashkenazi A., Ho D. O. J. Virol. 66:1992;235-243.
5. Orloff S. L., Bandea C. L., Kennedy M. S., Allaway G. P., Maddon P. J., Mcdougal J. S. AIDS Res. Hum. Retrovir. 11:1995;335-342.
6. Bradford M. M. Anal. Biochem. 72:1976;248-254.
7. Gulakowski R. J., McMahon J. B., Staley P. G., Moran R. A., Boyd M. R. J. Virol. Methods. 33:1991;87-100.
8. Hopp T. P., Prickett K. S., Price V., Libby R. T., March C. J., Cerretii P., Urdal D. L., Conlon P. J. Biotechnology. 6:1988;1205-1210.
9. Movra N. R., Nakamura K., Inouye M. J. Biol. Chem. 255:1980;27-29.